£12.0M
The financing round was led by Pfizer Ventures and accompanied by pro-rata contributions from existing investors.
"Since our initial investment in Mission seven years ago, the company has grown tremendously and the depth of its scientific expertise and capability has grown alongside it. We are proud to expand our relationship with the company and our scientists are looking forward to a successful collaboration in this important area of research."